Çмú´ëȸ VOD
´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Á¦59Â÷ Çмú´ëȸ
Korean Society of Coloproctology 59th Annual MeetingÀÏ ½Ã: 2026³â 3¿ù 27ÀÏ~ 3¿ù 29ÀÏ, Àå ¼Ò: ·Ôµ¥È£Åںλê
2026³â 3¿ù 27ÀÏ(±Ý)
[Abstract 1] IBD/Benign |
||||
| 09:30-09:37 | Impact of Intraoperative Controlled Urinary Leakage on Postoperative Adhesive Small Bowel Obstruction in Locally Advanced Colorectal Cancer | Á¶ÀºÇý | °í·Á´ëÇб³ ¾È¾Ïº´¿ø | ![]() |
| 09:37-09:45 | Clinical Characteristics and Prognosis of Pediatric-Onset Inflammatory Bowel Disease: A Nationwide Population-Based Study Using a 17-Year Age Cut off | ¹ÚÁØ¿µ | ÇѾçÀǴ뺴¿ø | ![]() |
| 09:45-09:52 | Procedure-Specific Learning Curves and Safety Adaptation in DaVinci¢ç SP-Robotic Colorectal Surgery | Á¶¼ººÀ | ¿¬¼¼ÀÇ´ë | ![]() |
| 09:52-10:00 | Age-Stratified Probability of Newly Diagnosed Crohn’s Disease in Patients Undergoing Surgery for Perianal Abscess or Fistula | ±èÁö¹Î | ¼¿ï¼Ûµµº´¿ø | |
| 10:00-10:07 | Emergent Hartmann’s Procedure for Colon Perforation: Over a 10-Year Review of Single Center | Á¤Àçö | ÀÎÇÏÀÇ´ë | ![]() |
| 10:07-10:15 | Preoperative Biologics Delay Disease Progression in Intestinal Behcet's Disease: A Retrospective Analysis | ½Åµ¿Çö | ¿¬¼¼ÀÇ´ë | |
| 10:15-10:22 | Risk Factors for Parastomal Hernia after Stoma Formation: The Protective Role of Stoma Placement within the Rectus Muscle | ¿ì»ó¾Æ | °Ç¾ç´ëÇб³º´¿ø | ![]() |
| 10:22-10:30 | Short-Term Outcomes of Minimally Invasive Extended Totally Extraperitoneal Repair (eTEP) for Ventral Hernias: A Single-Surgeon Experience | ±èÈ£½Â | ÀÌÈÀÇ´ë | ![]() |
[Abstract 2] AI & Other Research |
||||
| 09:30-09:40 | A Trajectory-Based Auto-Labeling Pipeline: A Novel Deep Learning Strategy for Identifying the Total Mesorectal Excision Plane | ÇÏÇå±Õ | Áß¾Ó´ëÇб³ ±¤¸íº´¿ø | ![]() |
| 09:40-09:50 | Deep Learning-Based Automated Detection and Classification of Stoma Complications in Clinical Photographs | Á¤Áø¹Î | ¾ÆÁÖÀÇ´ë | ![]() |
| 09:50-10:00 | Machine Learning Assisted Screening Method for Detection of Colorectal Cancer Risk Using Peripheral Blood Immune Cells | ±è´Ù¿î | ¼¿ï¼Ûµµº´¿ø | ![]() |
| 10:00-10:10 | Life Cycle Carbon Footprint of Laparoscopic and Robotic Low Anterior Resection in the Operating Room | ÃÖ¹ÌÁ¤ | ºÐ´ç¼¿ï´ëÇб³º´¿ø | |
| 10:10-10:20 | Machine Learning-Based Risk Scoring Using Clinical and Surgical Variables for Severe Complications After Rectal Cancer Surgery | ¼Û½ÂÈ£ | °æºÏ´ëÇб³º´¿ø | |
| 10:20-10:30 | User Perceptions of an Artificial Intelligence-Based Computer-Aided Detection System in Colonoscopy: A Single-Center Exploratory Survey Study | °í¼±¿µ | ±¹¸³¾Ï¼¾ÅÍ | ![]() |
[Abstract 3] Neoplasia I |
||||
| 09:30-09:40 | Upfront Surgery versus Preoperative Chemoradiation in Locally Advanced Mid Rectal Cancer: Reevaluating the Role of PCRT | °Àçö | ¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø | ![]() |
| 09:40-09:50 | Clinical Outcomes According to Treatment Modality and Lymph Node Metastasis Risk in Intermediate-Sized (10-20 mm) Rectal Neuroendocrine Tumors : A Multicenter Retrospective Study | ¹Ú¼º½Ç | ÇѾç´ë¼¿ïº´¿ø | |
| 09:50-10:00 | Is Tumor Size an Independent Prognostic Factor in Colon Cancer? A Propensity Score- Matched Study | ¾çÇö±Ô | ±¹¸³¾Ï¼¾ÅÍ | ![]() |
| 10:00-10:10 | CEA to Skeletal Muscle Index Ratio as a Novel Prognostic Marker in Patients with Colorectal Cancer | À̵¿Èñ | ±¹¹æºÎ, Àǹ«»ç·ÉºÎ | ![]() |
| 10:10-10:20 | Incidence, Risk Factors, and Clinical Significance of Portomesenteric Vein Thrombosis (PMVT) Detected After Colorectal Cancer Surgery: A Retrospective Analysis | ±èâȯ | °¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø | ![]() |
| 10:20-10:30 | Rethinking Surgical Strategy for Margin-Positive Only T1 Colorectal Cancer : Multicenter Retrospective Cohort Study of the Catholic Colorectal Group | ¹ÚÁøÇü | °¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø | ![]() |
[State-of-the-Art] Updates of Translational Research |
||||
| 10:40-11:00 | Organoids in the Management of Refractory Intestinal Ulcers | À¯Á¾¸¸ | Â÷ÀǰúÇдëÇб³, ¿À°¡³ëÀ̵å»çÀ̾𽺠| |
| 11:00-11:20 | Microbiome-Based Approaches for Treating Colorectal Diseases and Cancer | ¹ÚÇѼö | GIST, Áö³ð¾ØÄÄÆÛ´Ï | ![]() |
| 11:20-11:40 | Toward Next-Generation Cancer Vaccines in Colorectal Cancer | ½ÅÀÇö | KAIST, Ƽ¼¿·ÎÁö | |
| 11:40-12:00 | Decoding the Tumor Microenvironment of Colorectal Cancer Using Spatial Transcriptomics | ¹Ú¿õ¾ç | ¼º±Õ°ü´ëÇб³, Áö´Ï³Ê½º | |
[Áø·á±Ç°í¾ÈÀ§¿øÈ¸] Clinical Issues in Anal Cancer Management for Guideline Development |
||||
| 10:40-10:50 | Guideline Development Process Brief Report | À¯È¿¼± | °í·ÁÀÇ´ë | ![]() |
| 10:50-11:05 | Screening for Anal Cancer in High-risk Populations | ±ÇÀ±Çý | À»ÁöÀÇ´ë | |
| 11:05-11:20 | Assessment of Complete Response after CCRT | ¹®¼º°æ | °æÈñÀÇ´ë ¿µ»óÀÇÇаú | ![]() |
| 11:20-11:35 | Reduced-dose Radiotherapy in Early-stage Anal Cancer | ±èÅÂÇü | ¿¬¼¼ÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú | ![]() |
| 11:35-11:50 | Alternative Chemotherapy Regimens versus Mitomycin/5-FU based CRT | Áö¿õ¹è | °í·ÁÀÇ´ë | ![]() |
| 11:50-12:05 | Role of Local Excision in Stage 1 Anal Squamous Cell Carcinoma | ±è¹Î¼º | ÇѸ²ÀÇ´ë | ![]() |
[Neoplasia] Precision Medicine Meets Surgical Oncology in CRC |
||||
| 10:40-11:00 | Neoadjuvant Immunotherapy for MSI-H and MSS Rectal Cancer: Surgical Implications | Á¶¿ë¹ü | ¼º±Õ°üÀÇ´ë | ![]() |
| 11:00-11:20 | ctDNA-Guided Adjuvant Therapy: When to Escalate or De-escalate | Â÷¿ëÁØ | ¾ÆÀÌ¿¥ºñµð¿¢½º | |
| 11:20-11:40 | Molecular Profiling-Based Treatment Strategies for Metastatic CRC | ÇÏ±â¿ø | ÀüºÏÀÇ´ë | |
| 11:40-12:00 | Gut Microbiome and Treatment Response in CRC | Á¤°æ¿í | ¼º±Õ°üÀÇ´ë | ![]() |
Luncheon Symposium 1 [Livsmed] |
||||
| 12:10-12:40 | Colorectal Surgery Using the ArtiSeal: A New Standard for Hemostasis and Precision | ¹è¼º¿í | °è¸íÀÇ´ë | ![]() |
Luncheon Symposium 2 [Daewoong] |
||||
| 12:10-12:40 | Á÷Àå¾Ï ¼ö¼ú ÈÄ ¹èº¯ Àå¾Ö °ü¸®¿Í º¯½Ç±Ý Ä¡·áÀÇ »õ·Î¿î ¿É¼Ç: Ramosetron (À̸®ÄÝÁ¤¢ç) | À¯½Â¹ü | ¼¿ïÀÇ´ë | ![]() |
Luncheon Seminar 1 [Medtronic] |
||||
| 12:10-12:40 | Fast and Safe Surgery with LigaSure¢â | ±èÂù¿í | ¿ï»êÀÇ´ë | |
[Chemotherapy] Optimizing TNT Strategy in LARC: Key Debates and Protocol Sharing |
||||
| 13:20-13:40 | Why We Choose RT Followed by Consolidation Chemotherapy | ±èÇýÁø | °æºÏÀÇ´ë | ![]() |
| 13:40-14:00 | Why We Choose Induction Chemotherapy with Selective RT Strategy | ÀÌÀ±¼® | °¡Å縯ÀÇ´ë | ![]() |
| 14:00-14:20 | Does TNT Really Improve Outcomes? Gap of Evidence and Real Clinical Practice | ±èâ¿ì | ¾ÆÁÖÀÇ´ë | ![]() |
| 14:20-14:40 | Is Watch-and-Wait Feasible in Korea? Initial Experience and Cultural Barriers | ¹ÚÀ±¿µ | °æÈñÀÇ´ë | |
[Benign Colorectal Disease] Multidisciplinary Approach to Emergency Surgery for Benign Colorectal Disease |
||||
| 13:20-13:35 | Let the Surgeon Sleep, Keep the Patient Safe: Evidence-Based Timing for Semi-Urgent Colorectal Surgery | ÀÌ´ë¼· | ºÎ»êÀÇ´ë ÀÀ±ÞÀÇÇаú | ![]() |
| 13:35-13:50 | Drain Today, Operate Right | ³²ÀÎÃâ | Á¦ÁÖÀÇ´ë ¿µ»óÀÇÇаú | |
| 13:50-14:05 | Resuscitation Strategy in Postoperative Septic Shock | ÀÌ°æ¿ø | À»ÁöÀÇ´ë ÁßȯÀÚÀÇÇаú | ![]() |
| 14:05-14:20 | Surgeon-Anesthesiologist Communication Checklist for Colorectal Emergencies | ±èÈñ¿µ | ºÎ»êÀÇ´ë ¸¶Ãë°ú | ![]() |
| 14:20-14:50 | Panel Discussion | ±èÇѱæ | °æ»óÀÇ´ë | ![]() |
| 14:20-14:50 | Panel Discussion | ¿Àâ±Ô | ¼º±Õ°üÀÇ´ë | ![]() |
[KQIPS-CRS Workshop] Korean Quality Improvement Platform in Colon and Rectal Surgery |
||||
| 13:20-13:35 | KQIPS-CRS: Building a National Prospective Quality Improvement Platform | ¾öÁØ¿ø | °í·ÁÀÇ´ë | ![]() |
| 13:35-13:50 | Practical Considerations: IRB Approval and Informed Consent | À±¼ø¼® | °í·ÁÀÇ´ë | ![]() |
| 13:50-14:05 | Prospective eCRF Platform and Data Management | ±Ç¿Àö | MDB Inc. | ![]() |
| 14:05-14:20 | From Contract to Management: Budget Execution | ¾ÈÄ¡¹ü | °í·ÁÀÇ´ë | |
| 14:20-14:35 | Development of Guidelines & Clinical Pathways | ºÀÁØ¿ì | °í·ÁÀÇ´ë | ![]() |
| 14:35-14:50 | Unified Data, Unified Strength: The Strategic Future of KSCP | ¹ÚÁö¿ø | ¼¿ïÀÇ´ë | ![]() |
[Debate_Neoplasia] Organ Preservation for Rectal Cancer |
||||
| 15:10-15:25 | Organ Preservation for cT2N0 Rectal Cancer. Two Strategies in Focus. Local Excision Followed by Adjuvant Chemotherapy or Radiotherapy |
ÇãÁ¤¿í | ¼º±Õ°üÀÇ´ë | |
| 15:25-15:40 | Organ Preservation for cT2N0 Rectal Cancer. Two Strategies in Focus. Neoadjuvant Treatment Followed by Watch-and-Wait or Local Excision |
À̵¿¿î | ±¹¸³¾Ï¼¾ÅÍ | ![]() |
| 15:40-15:55 | Managing Positive Margins after Local Excision in Early Rectal Cancer Re-local Excision or Adjuvant Treatment Aiming Organ Preservation |
¹èÁ¤ÈÆ | °¡Å縯ÀÇ´ë | ![]() |
| 15:55-16:10 | Managing Positive Margins after Local Excision in Early Rectal Cancer Why TME Remains the Oncologically Safe Choice |
±è¿µÀÏ | ¿ï»êÀÇ´ë | ![]() |
[Surgical Assistant] Surgeon-Surgical Assistants Collaboration to Ensure Safe and High-Quality Surgery |
||||
| 15:10-15:25 | Proactive Strategies by Surgical Assistant in Enhancing Intraoperative Flow | À̹ÌÁö | ºÎ»ê¹éº´¿ø | ![]() |
| 15:25-15:40 | Enhancing the Role of the Surgical Assistant in Colorectal Surgery | ¼º³«¼Û | °Ç¾çÀÇ´ë | ![]() |
| 15:40-15:55 | Advancing Surgical Skill and Professional Development Strategies for the Surgical Assistant | ÃÖÀ¸¶ä | ¼¿ï¾Æ»êº´¿ø | |
| 15:55-16:10 | What is the Critical Competency of a Surgical Assistant to Contribute to Emergency Surgery or Terrible Situations? | ±èÇѱæ | °æ»óÀÇ´ë | ![]() |
| 16:10-16:40 | Panel Discussion | ±ÇÇý¿¬ | ¿¬¼¼¿øÁÖÀÇ´ë | ![]() |
[AI Workshop] ´ëÀåÇ×¹®¿Ü°úÀǸ¦ À§ÇÑ AI ¸®ÅÍ·¯½Ã |
||||
| 15:10-15:30 | ¿¬±¸ ¼³°è ¹× ÀÚ·á Ž»öÀÇ ³ëÇÏ¿ì ¾Ë±â | ÃÖ¿µÁØ | ·çºñÄÜ Å×Å© | ![]() |
| 15:30-15:50 | ¿¬±¸ÀÚ·á Á¤¸®, Åë°è ºÐ¼® ÀÚµ¿È ±â¹ý ¹è¿ì±â | ÃÖ¿µÁØ | ·çºñÄÜ Å×Å© | ![]() |
| 15:50-16:10 | ³í¹® ÃÊ¾È ÀÛ¼º ¹× Åõ°íÀü ÇǾºä ½Ã¹Ä·¹ÀÌ¼Ç È°¿ëÇϱâ | ÃÖ¿µÁØ | ·çºñÄÜ Å×Å© | ![]() |
| 16:10-16:30 | ¿¬±¸ ±×·¡ÇÈ ¹× ¹ßÇ¥ PPT »ý¼º ¹æ¹ý ¸¶½ºÅÍÇϱâ | ÃÖ¿µÁØ | ·çºñÄÜ Å×Å© | ![]() |
[Abstract 4] Neoplasia II |
||||
| 17:00-17:10 | Indirect Validation of a Total Neoadjuvant Therapy Protocol in Locally Advanced Rectal Cancer Using an AI-Based Multidisciplinary Simulation | °½Â¿¬ | ¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø | ![]() |
| 17:10-17:20 | Diagnostic Performance of Sigmoidoscopy and MRI in Patients Suspected of Good Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer | ÀÌÈ£¿µ | ºÐ´ç¼¿ï´ëÇб³º´¿ø | ![]() |
| 17:20-17:30 | The Paradoxical Features of Tumor Size in T4 Colon Cancer: A Retrospective Cohort Study | ÀåÁø±â | ¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø | |
| 17:30-17:40 | Patient Preferences for Robotic Surgery in Low-Risk Thyroid Cancer Versus High-Risk Colorectal Cancer | ±è¿µÀÏ | ¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø | ![]() |
| 17:40-17:50 | Risk Factors for Lateral Pelvic Node Recurrence After Total Mesorectal Excision in Rectal Cancer Patients With Responsive Lateral Pelvic Nodes Following Chemoradiotherapy | °°æ¹Î | ºÐ´ç¼¿ï´ëÇб³º´¿ø | ![]() |
| 17:50-18:00 | Learning Curve of Da Vinci Single-Port Robotic Colorectal Cancer Surgery: Impact of Prior Robotic Experience | À̼ö¿µ | ȼøÀü³²´ëÇб³º´¿ø | ![]() |
[Abstract 5] Translational Research |
||||
| 17:00-17:10 | Circulating Microbial Cell-Free DNA with Unmethylated CpG Motifs as a Novel Biomarker for T-Cell Exhaustion and Immunotherapy Resistance in Colorectal Cancer | °µ¿Çö | ¼øÃµÇâ´ëÇб³ ºÎ¼Ó õ¾Èº´¿ø | |
| 17:10-17:20 | Evaluation of the Cancer-Inhibitory Effect of Attenuated Salmonella in Colorectal Cancer Peritoneal Metastasis: A Syngeneic Mouse Model | ¹ÚÇü¹Î | ȼøÀü³²´ëÇб³º´¿ø | |
| 17:20-17:30 | Single-Cell RNA-Sequencing and Spatial Transcriptomics Integration Identifies a Neuro-Mesenchymal Niche Driving Perineural Invasion in Colorectal Cancer | Ç¥´ëÈñ | °¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø | |
| 17:30-17:40 | Integrated Transcriptomic and Genomic Analysis of the Tumor Immune Microenvironment and Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer | ±èÈ¿ÁØ | ¼¿ï´ëÇб³º´¿ø | ![]() |
| 17:40-17:50 | Myogenic Maturation of Adipose-Derived MSC Spheroids Enhances Muscle Reconstruction in a Mouse Model of Anal Sphincter Injury | ¾çÀÎÁØ | Ãæ³²´ëÇб³º´¿ø | |
| 17:50-18:00 | Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Enhances Growth Inhibition in Solid Tumor Cell Lines | ±èÁø¼ö | Ãæ³²´ëÇб³º´¿ø | ![]() |
[Abstract 6] Neoplasia III |
||||
| 17:00-17:10 | Local Excision with Chemoradiotherapy as an Alternative to Curative Resection for Stage I Rectal Cancer | ¹éÁøÈñ | °Ç±¹ÀÇ´ë | |
| 17:10-17:20 | Lymphopenia and CRP Elevation on the Postoperative Day 2 Are Independent Risk Factors for Detection of Major and Minor Complications in Elective Colorectal Cancer Surgery | ¹Ú¹Î¼ | Á¶¼±ÀÇ´ë | |
| 17:20-17:30 | Optimal Surgical Timing of Resectable Colorectal Liver Metastases | ±èµ¿ÇÏ | Ãæ³²´ëÇб³º´¿ø | ![]() |
| 17:30-17:40 | Risk of Metabolic Disease After Right- vs Left-Sided Colectomy for Colon Cancer: A Nationwide Cohort Study | ¿À¼ö¿µ | ¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø | |
| 17:40-17:50 | Comparison of Treatment Outcomes Before and After Implementation of Integrated Nursing Care Services in Colorectal Cancer Surgery under ERAS | ¹Ú¼öÁö | °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø | |
| 17:50-18:00 | Serial ctDNA Monitoring in Stage IV Colorectal Cancer: Final Results | ±èÇö°æ | °¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø | |





